Conference abstract · 21 Nov 2016
Conference abstractPublished 15 Sep 2014
Epigenetic approaches in cancer therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The National Institutes of Health (NIH) has initiated the Epigenomics Roadmap Program which is comprised of five major initiatives: Reference Epigenome Mapping Centers, Epigenomic Data Analysis and Coordinating Centers, Technology Development in Epigenetics, Discovery of Novel Epigenetic Marks, Epigenomics of Human Health and Diseases. This program proposes that the origins of health and susceptibility to disease are the result of epigenetic regulation of the genetic information. Specifically, epigenetic mechanisms that control stem cell differentiation and organogenesis contribute to the biological response to environmental and other factors in the form of stimuli that contribute in disease development. Epigenetic and genetic approaches in cancer epidemiology and risk assessment will be discussed. Epidemiology is the scientific study of the causes and distribution of disease in populations. The National Cancer Institute?s Epidemiology and Genetics Research Program (EGRP), in the Division of Cancer Control and Population Sciences, provides opportunities for investigators to increase understanding of cancer causes and prevention in human populations. EGRP supports research in four areas: (1) Clinical and translational epidemiology, including factors that influence development of cancer among persons with underlying diseases and conditions; the progression, recurrence, and mortality from cancer; and development of new primary cancers; (2) Host susceptibility factors that influence personal susceptibility to cancer in humans, such as genetic, epigenetic, immunological, hormonal, and biological pathways; and social, cultural, racial, and ethnic factors; (3) Methods and technologies for epidemiologic data collection, study design and analysis, and development and adaptation of laboratory and technical approaches for large studies in human populations; (4) Modifiable risk factors to reduce cancer risk in humans, such as diet and nutrition; alcohol; physical activity and energy balance; tobacco; infectious diseases; physical and chemical agents; and medical exposures, including medications and treatments. Different funding mechanisms of grants and contracts, and collaboration opportunities will be discussed.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 29 Aug 2025
Epigenetic Signatures: Predicting Breast Cancer Prognosis and Therapy
Research article · 30 Jun 2025
Epigenetics: Driving Gynecologic Cancers and Therapies
Commentary · 29 May 2025
Cancer Mechanisms: Oncogenes, KRAS, Epigenetics, Therapies
Perspective · 17 Mar 2025
Epigenetic Modifications in Cancer: A New Frontier in Diagnosis and Therapy
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mukesh Verma”

